Tr1X to Participate at Upcoming Healthcare Investment Conferences

Blue shape

You might also be interested in...

November 14, 2025

The BioHub Podcast with David de Vries, Co-Founder, CEO, discussing Tr1X's pipeline of Type-1 regulatory T cells

View

View

October 24, 2025

Scaling Smarter: a Case Study in Overcoming Cell Therapy Manufacturing & Regulatory Hurdles

View

View

October 15, 2025

Tr1X Announces FDA Clearance of IND Application for TRX319, a First-in-Class Allogeneic CAR-Tr1 Treg Cell Therapy for Progressive Multiple Sclerosis, and $50 Million in Additional Financing

View

View